CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −686 | $78.71 | $54K | 111,419 |
| 2026-01-09 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −107 | $79.52 | $9K | 111,312 |
| 2026-01-09 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,722 | $77.41 | $133K | 81,165 |
| 2026-01-08 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,514 | $76.45 | $192K | 394,453 |
| 2026-01-08 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,034 | $76.45 | $79K | 72,693 |
| 2026-01-08 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Sale 10b5-1 | −866 | $76.45 | $66K | 92,428 |
| 2026-01-08 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −2,482 | $76.56 | $190K | 115,177 |
| 2026-01-08 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −265 | $77.07 | $20K | 114,912 |
| 2026-01-08 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,286 | $76.45 | $98K | 113,626 |
| 2026-01-08 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −881 | $76.45 | $67K | 115,196 |
| 2026-01-08 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −59 | $76.45 | $5K | 6,791 |
| 2026-01-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −2,561 | $76.42 | $196K | 84,928 |
| 2026-01-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −587 | $76.98 | $45K | 84,341 |
| 2026-01-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,454 | $76.45 | $111K | 82,887 |
| 2026-01-07 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,016 | $77.48 | $234K | 396,967 |
| 2026-01-07 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,235 | $77.45 | $96K | 73,727 |
| 2026-01-07 | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Sale 10b5-1 | −642 | $77.48 | $50K | 93,294 |
| 2026-01-07 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,503 | $77.48 | $116K | 117,659 |
| 2026-01-07 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +2,625 | $38.10 | $100K | 120,284 |
| 2026-01-07 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,638 | $77.11 | $126K | 118,646 |
Page 10 of 25 · 493 trades